Tilley WD - Search Results

1

ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.

Centenera MM, Scott JS, Machiels J, Nassar ZD, Miller DC, Zinonos I, Dehairs J, Burvenich IJG, Zadra G, Chetta PM, Bango C, Evergren E, Ryan NK, Gillis JL, Mah CY, Tieu T, Hanson AR, Carelli R, Bloch K, Panagopoulos V, Waelkens E, Derua R, Williams ED, Evdokiou A, Cifuentes-Rius A, Voelcker NH, Mills IG, Tilley WD, Scott AM, Loda M, Selth LA, Swinnen JV, Butler LM. Centenera MM, et al. Among authors: tilley wd. Cancer Res. 2021 Apr 1;81(7):1704-1718. doi: 10.1158/0008-5472.CAN-20-2511. Epub 2021 Feb 5. Cancer Res. 2021. PMID: 33547161

2

Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells.

Hall RE, Tilley WD, McPhaul MJ, Sutherland RL. Hall RE, et al. Among authors: tilley wd. Int J Cancer. 1992 Nov 11;52(5):778-84. doi: 10.1002/ijc.2910520518. Int J Cancer. 1992. PMID: 1428232

3

Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis.

Tilley WD, Lim-Tio SS, Horsfall DJ, Aspinall JO, Marshall VR, Skinner JM. Tilley WD, et al. Cancer Res. 1994 Aug 1;54(15):4096-102. Cancer Res. 1994. PMID: 7518349

4

Evidence for a novel mechanism of androgen resistance in the human prostate cancer cell line, PC-3.

Tilley WD, Bentel JM, Aspinall JO, Hall RE, Horsfall DJ. Tilley WD, et al. Steroids. 1995 Jan;60(1):180-6. doi: 10.1016/0039-128x(94)00031-7. Steroids. 1995. PMID: 7792809

5

Androgen receptors in prostate cancer.

Bentel JM, Tilley WD. Bentel JM, et al. Among authors: tilley wd. J Endocrinol. 1996 Oct;151(1):1-11. doi: 10.1677/joe.0.1510001. J Endocrinol. 1996. PMID: 8943763 Review. No abstract available.

6

Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.

Hall RE, Clements JA, Birrell SN, Tilley WD. Hall RE, et al. Among authors: tilley wd. Br J Cancer. 1998 Aug;78(3):360-5. doi: 10.1038/bjc.1998.499. Br J Cancer. 1998. PMID: 9703283 Free PMC article.

7

Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer.

Ricciardelli C, Mayne K, Sykes PJ, Raymond WA, McCaul K, Marshall VR, Tilley WD, Skinner JM, Horsfall DJ. Ricciardelli C, et al. Among authors: tilley wd. Clin Cancer Res. 1997 Jun;3(6):983-92. Clin Cancer Res. 1997. PMID: 9815775

8

Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

Tilley WD, Buchanan G, Hickey TE, Bentel JM. Tilley WD, et al. Clin Cancer Res. 1996 Feb;2(2):277-85. Clin Cancer Res. 1996. PMID: 9816170

9

Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer.

Ricciardelli C, Quinn DI, Raymond WA, McCaul K, Sutherland PD, Stricker PD, Grygiel JJ, Sutherland RL, Marshall VR, Tilley WD, Horsfall DJ. Ricciardelli C, et al. Among authors: tilley wd. Cancer Res. 1999 May 15;59(10):2324-8. Cancer Res. 1999. PMID: 10344737

10

Role of the androgen receptor in human breast cancer.

Birrell SN, Hall RE, Tilley WD. Birrell SN, et al. Among authors: tilley wd. J Mammary Gland Biol Neoplasia. 1998 Jan;3(1):95-103. doi: 10.1023/a:1018730519839. J Mammary Gland Biol Neoplasia. 1998. PMID: 10819508 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page